3SBio Inc. (TRSBF)
OTCMKTS · Delayed Price · Currency is USD
4.415
0.00 (0.00%)
Sep 7, 2025, 8:00 PM EDT
3SBio Market Cap
3SBio has a market cap or net worth of $11.03 billion as of September 9, 2025. Its market cap has increased by 461.49% in one year.
Market Cap
11.03B
Enterprise Value
10.75B
Revenue
1.27B
Ranking
n/a
PE Ratio
33.49
Stock Price
$4.42
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 2.92B to 11.03B, an increase of 277.11%. That is a compound annual growth rate of 13.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 11.03B | 498.09% |
| Dec 31, 2024 | 1.84B | -20.16% |
| Dec 29, 2023 | 2.31B | -11.06% |
| Dec 30, 2022 | 2.60B | 23.47% |
| Dec 31, 2021 | 2.10B | -9.35% |
| Dec 31, 2020 | 2.32B | -29.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |